Amedica Announces Participation in 2015 Ladenburg Thalmann Healthcare Conference
SALT LAKE CITY, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced its expected participation in the following investor conference:
| 2015 Ladenburg Thalmann Healthcare Conference |
| Tuesday, September 29, 2015 |
| 11:30 AM Eastern Time |
| New York, NY |
| Dr. Sonny Bal, Chairman and CEO, will conduct a formal presentation and participate in one-on-one meetings. |
This event will be available via webcast at the specified start time on the Investor Relations section of the Amedica website, investors.amedica.com. The replay will also be available on the website for 90 days following the conference.
About Amedica Corporation
Amedica is focused on the development and application of medical-grade silicon nitride ceramics. Amedica markets spinal fusion products and is developing a new generation of wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company manufactures its products in its ISO 13485 certified manufacturing facility and through its partnership with Kyocera, the world's largest ceramic manufacturer. Amedica's spine products are FDA-cleared, CE-marked, and are currently marketed in the U.S. and select markets in Europe and South America through its distributor network and its growing OEM partnerships.
For more information on Amedica or its silicon nitride material platform, please visit www.amedica.com.
Contact: Mike Houston VP, Commercialization & Communications 801-839-3534 IR@amedica.com
Released September 15, 2015